CAAS Capital Management’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.08K | Hold |
75,000
| – | – | ﹤0.01% | 159 |
|
|
2024
Q4 | $3.56K | Hold |
75,000
| – | – | ﹤0.01% | 92 |
|
|
2024
Q3 | $3.17K | Hold |
75,000
| – | – | ﹤0.01% | 85 |
|
|
2024
Q2 | $3.37K | Hold |
75,000
| – | – | ﹤0.01% | 60 |
|
|
2024
Q1 | $2.26K | Hold |
75,000
| – | – | ﹤0.01% | 108 |
|
|
2023
Q4 | $4.5K | Hold |
75,000
| – | – | ﹤0.01% | 118 |
|
|
2023
Q3 | $3.8K | Hold |
75,000
| – | – | ﹤0.01% | 208 |
|
|
2023
Q2 | $3.76K | Hold |
75,000
| – | – | ﹤0.01% | 189 |
|
|
2023
Q1 | $3.14K | Hold |
75,000
| – | – | ﹤0.01% | 259 |
|
|
2022
Q4 | $5.99K | Hold |
75,000
| – | – | ﹤0.01% | 395 |
|
|
2022
Q3 | $8K | Hold |
75,000
| – | – | ﹤0.01% | 409 |
|
|
2022
Q2 | $13K | Buy |
+75,000
| New | +$13K | ﹤0.01% | 393 |
|